EBS:NYE-Emergent Biosolutions Inc (USD)

COMMON STOCK | Drug Manufacturers - Specialty & Generic |

Last Closing

USD 6.05

Change

-0.28 (-4.42)%

Market Cap

N/A

Volume

1.08M

Analyst Target

USD 112.29
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-06-05 )

Largest Industry Peers for Drug Manufacturers - Specialty & Generic

Symbol Name Price(Change) Market Cap
ZTS Zoetis Inc

+0.02 (+0.01%)

USD 72.38B
HLN Haleon plc

+0.19 (+1.74%)

USD 50.16B
TAK Takeda Pharmaceutical Co Ltd A..

-0.04 (-0.27%)

USD 44.08B
RDY Dr. Reddy’s Laboratories Ltd..

+0.78 (+5.29%)

USD 11.96B
IPSEF Ipsen S.A

N/A

USD 9.50B
ELAN Elanco Animal Health

-0.01 (-0.07%)

USD 6.42B
AMRX Amneal Pharmaceuticals, Inc. C..

-0.04 (-0.55%)

USD 3.54B
BHC Bausch Health Companies Inc

-0.01 (-0.22%)

USD 1.73B
YCBD cbdMD Inc

+0.01 (+1.51%)

USD 8.19M
CPHI China Pharma Holdings Inc

-0.13 (-7.88%)

USD 7.24M

ETFs Containing EBS

PIEQ Principal International E.. 3.59 % 0.00 %

+0.26 (+0.92%)

USD 0.74B
FPXE:LSE First Trust IPOX® Europe.. 2.66 % 0.00 %

+11.90 (+0.92%)

USD 1.04M
EMUM:SW iShares MSCI EMU Mid Cap .. 1.90 % 0.00 %

-0.12 (0.92%)

USD 0.22B
LDEG:LSE L&G Quality Equity Divide.. 1.30 % 0.00 %

+3.30 (+0.92%)

N/A
EUMD:LSE iShares MSCI Europe Mid C.. 1.14 % 0.00 %

+0.03 (+0.92%)

USD 0.49B
FPXE First Trust IPOX Europe E.. 0.00 % 0.00 %

+0.13 (+0.92%)

USD 4.36M
IS3H:F iShares IV Public Limited.. 0.00 % 0.00 %

+0.21 (+0.92%)

N/A
C005:XETRA Amundi Index Solutions - .. 0.00 % 0.00 %

+1.28 (+0.92%)

USD 0.13B
EL43:XETRA Deka MSCI Europe MC UCITS.. 0.00 % 0.00 %

+0.07 (+0.92%)

USD 0.02B
IS3H:XETRA iShares MSCI EMU Mid Cap .. 0.00 % 0.00 %

+0.50 (+0.92%)

N/A
IS3T:XETRA iShares MSCI World Size F.. 0.00 % 0.00 %

+0.02 (+0.92%)

N/A
FTEU:LSE First Trust Eurozone Alph.. 0.00 % 0.00 %

+0.67 (+0.92%)

USD 0.05B
FTGE:XETRA First Trust Eurozone Alph.. 0.00 % 0.00 %

+0.48 (+0.92%)

N/A
IWSZ:SW iShares Edge MSCI World S.. 0.00 % 0.00 %

N/A

USD 0.28B

Market Performance

  Market Performance vs. Industry/Classification (Drug Manufacturers - Specialty & Generic) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -36.72% 13% F 4% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -36.72% 13% F 4% F
Trailing 12 Months  
Capital Gain -3.35% 40% F 34% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -3.35% 33% F 28% F
Trailing 5 Years  
Capital Gain -93.04% 14% F 1% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -93.04% 14% F 1% F
Average Annual (5 Year Horizon)  
Capital Gain -1.91% 33% F 28% F
Dividend Return -1.91% 33% F 16% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 133.97% 20% F 5% F
Risk Adjusted Return -1.43% 33% F 24% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector